Electronic adjudication metrics give us unprecedented visibility into operational performance. But making the most of these capabilities requires more than collecting data. It starts with a strategic question: have we clearly defined what success looks like?
We measure almost everything in clinical development. Yet one fundamental question does not always receive the attention it deserves: what exactly are we trying to achieve?
In clinical endpoint adjudication, we monitor event volumes, turnaround times, reviewer workloads, and quality indicators. Dashboards display the numbers, reports summarize progress, and teams investigate deviations.
But how can we determine whether adjudication is performing successfully if we have not defined success in the first place?
The challenge is certainly not a lack of performance data. It is that we too often start measuring before even having decided what successful performance should look like.
Applying the Principles of Clinical Research
In clinical trials, we define objectives, endpoints, and analysis strategies before collecting data. We recognize that meaningful conclusions depend on asking the right questions from the outset.
Why should operational performance measurement be different?
Defining success may be easier said than done. Under pressure to launch studies, establish workflows, and meet demanding timelines, relying on familiar indicators and existing dashboards is understandable.
Taking the time to reconsider what really matters could therefore seem like another task in an already demanding schedule. Yet, that initial investment may ultimately save considerable time.
From Measuring Activity to Guiding Decisions
Consider a dashboard showing 50 cases awaiting review.
Is that acceptable? Does it indicate a developing backlog? Should someone intervene?
The number alone cannot answer these questions. Its significance depends on expected event volumes, reviewer capacity, study timelines, and trends over time.
This is where a more strategic approach makes the difference.
We need to identify which processes are critical to success, select indicators that reflect their performance, and establish thresholds that distinguish normal variation from emerging risks.
Importantly, not every deviation requires intervention. Excessive alerts can obscure meaningful signals and create additional work rather than improve oversight.
The real value of KPIs lies in helping teams recognize when attention is needed, understand why, and take appropriate action.
Making Technology Work Harder for Us
Electronic adjudication platforms have transformed our ability to collect, visualize, and analyze operational data. Increasingly, they also offer the capability to identify patterns and anticipate potential bottlenecks.
But technology alone does not make a process more effective.
To fully leverage these capabilities, we must connect performance indicators to clear objectives, meaningful thresholds, and predefined actions.
This requires moving beyond passive monitoring toward a more strategic approach to adjudication management.
It also means defining responsibilities, evaluating the effectiveness of corrective actions, and applying lessons learned to future studies.
The opportunity is not simply to process cases faster, but to manage adjudication more consistently, proactively, and in alignment with the study's scientific objectives.
Success Starts With a Clear Definition
In conclusion, the most valuable question is not whether we have enough KPIs, but whether we have taken the time to define what success should look like and how we will recognize it.
Why? Because the true potential of electronic endpoint adjudication is realized not when we collect more data, but when we use it to make better decisions.